• Home
  1. Home
  2. Ophthalmic Insert versus Eye Drops for Mydriasis in Neonates: A Randomized Clinical Trial
Scientific article
English

Ophthalmic Insert versus Eye Drops for Mydriasis in Neonates: A Randomized Clinical Trial

ContributorsBremond-Gignac, Dominique; Jacqz-Aigrain, Evelyne; Abdoul, Hendy; Daruich, Alejandra; Beresniak, Ariel; Baud, Olivier; Alberti, Corinne; CLAIR FO Study Group
Published inNeonatology, vol. 115, no. 2, p. 142-148
Publication date2019
Abstract

Eye drop treatment routinely used to obtain mydriasis prior to fundoscopy in neonates requires repeated instillations of mydriatic agents that can lead to systemic side effects. The aim of this study was to compare the mydriatic efficacy and tolerance of administration of phenylephrine and tropicamide via the ophthalmic insert Mydriasert® versus standard eye drop treatment in neonates.

Keywords
  • Blood Pressure/drug effects
  • Female
  • Heart Rate/drug effects
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mydriatics/administration & dosage
  • Ophthalmic Solutions/administration & dosage
  • Phenylephrine/administration & dosage
  • Prospective Studies
  • Pupil/drug effects
  • Single-Blind Method
  • Tropicamide/administration & dosage
  • Mydriasis
  • Neonates
  • Retinopathy of prematurity
Affiliation entities
Research groups
Citation (ISO format)
BREMOND-GIGNAC, Dominique et al. Ophthalmic Insert versus Eye Drops for Mydriasis in Neonates: A Randomized Clinical Trial. In: Neonatology, 2019, vol. 115, n° 2, p. 142–148. doi: 10.1159/000493723
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Additional URL for this publicationhttps://www.karger.com/Article/Abstract/493723
Journal ISSN1661-7800
353views
0downloads

Technical informations

Creation23/06/2020 12:52:00
First validation23/06/2020 12:52:00
Update15/03/2023 22:11:25
Status update15/03/2023 22:11:24
Last indexation31/10/2024 19:02:31
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack